Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis Patients (CHAMBER): A Multicenter, Double-blind, Randomized, Placebo-controlled Trial

NCT02214563 is registered in ClinicalTrials.gov with Takayuki Hamano as lead sponsor.

NCT NCT02214563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02214563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis Patients (CHAMBER): A Multicenter, Double-blind, Randomized, Placebo-controlled Trial
Lead sponsor
Takayuki Hamano
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2014
Completion date
December 31, 2016
Enrollment
90 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, bone diseases, metabolic, kidney failure, chronic, vitamin d deficiency